Sanderling VI Limited Partnership
Insider CIK 1429282 · CMRX 10% owner · ECYT 10% owner · PCRX Director, 10% owner · CALC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CALC CalciMedica, Inc. | P Buy | 2024-11-01 | 2024-11-05 | 86,867 | $3.75 | $325.8K | 814,300 | SEC↗ |
| CALC CalciMedica, Inc. | P Buy | 2024-11-01 | 2024-11-05 | 877 | $3.75 | $3.3K | 22,479 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 8,393 | — | $0 | 8,393 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 12,380 | — | $0 | 12,380 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 2,203 | — | $0 | 2,203 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 3,249 | — | $0 | 3,249 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 569 | — | $0 | 569 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 840 | — | $0 | 840 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 113 | — | $0 | 113 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 167 | — | $0 | 167 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 2,672 | — | $0 | 2,672 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 16,539 | — | $0 | 16,539 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 2,685 | — | $0 | 2,685 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 1,910 | — | $0 | 1,910 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 6,852 | — | $0 | 6,852 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 15,403 | — | $0 | 15,403 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 183 | — | $0 | 183 | SEC↗ |
| CALC CalciMedica, Inc. | A Award deriv | 2023-03-20 | 2023-10-10 | 237 | — | $0 | 237 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 14,425 | — | $0 | 14,425 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 703,388 | — | $0 | 703,388 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 1,548 | — | $0 | 1,548 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 63,228 | — | $0 | 63,228 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 582,757 | — | $0 | 582,757 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 240,676 | — | $0 | 240,676 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 8,884 | — | $0 | 8,884 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 7,456 | — | $0 | 7,456 | SEC↗ |
| CALC CalciMedica, Inc. | A Award | 2023-03-20 | 2023-10-10 | 17,682 | — | $0 | 17,682 | SEC↗ |
| CMRX CHIMERIX INC | J Other | 2013-11-13 | 2013-11-15 | 7,543 | — | $0 | 4,153,650 | SEC↗ |
| CMRX CHIMERIX INC | J Other | 2013-11-13 | 2013-11-15 | 94,633 | — | $0 | 4,161,193 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 792,037 | — | $0 | 4,143,152 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 619,852 | — | $0 | 3,213,626 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 183,096 | — | $0 | 183,096 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 474,330 | — | $0 | 657,426 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 469,480 | — | $0 | 1,126,906 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 771,372 | — | $0 | 2,593,774 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-04-16 | 695,496 | — | $0 | 1,822,402 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion | 2013-04-16 | 2013-05-28 | 792,037 | — | $0 | 4,255,826 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-19 | 2013-03-20 | 46,339 | $26.95 | $1.25M | 416,083 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-19 | 2013-03-20 | 38,250 | $27.66 | $1.06M | 462,422 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 28,956 | $29.20 | $845.5K | 530,497 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 23,969 | $29.20 | $699.9K | 24,688 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 28,558 | $29.20 | $833.9K | 29,415 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 29,825 | $28.19 | $840.8K | 500,672 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 24,688 | $28.19 | $696.0K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-18 | 2013-03-20 | 29,415 | $28.19 | $829.2K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-15 | 2013-03-20 | 1,000,000 | — | $0 | 361,762 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-15 | 2013-03-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-15 | 2013-03-20 | 200,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-15 | 2013-03-20 | 25,133 | — | $0 | 67,966 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-04-15 | 348,951 | $27.86 | $9.72M | 559,453 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-03-11 | 348,951 | $27.86 | $9.72M | 559,453 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 843 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 629 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 750 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 17,839 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 20,220 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 708 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 20,069 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-04-15 | 17,973 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 368 | $25.92 | $9.5K | 48,657 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 10,485 | $25.92 | $271.8K | 908,404 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 438 | $25.92 | $11.4K | 57,973 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 10,407 | $25.92 | $269.7K | 1,361,762 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 17,973 | $2.69 | $48.3K | 900,535 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 629 | $2.69 | $1.7K | 48,383 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 750 | $2.69 | $2.0K | 57,646 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 17,839 | $2.69 | $48.0K | 1,353,952 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 1,866 | $25.92 | $48.4K | 898,669 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 20,069 | $13.44 | $269.7K | 1,372,169 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 843 | $13.44 | $11.3K | 58,411 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 708 | $13.44 | $9.5K | 49,025 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-04-15 | 20,220 | $13.44 | $271.8K | 918,889 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 1,852 | $25.92 | $48.0K | 1,352,100 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 78 | $25.92 | $2.0K | 57,568 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-04-15 | 66 | $25.92 | $1.7K | 48,317 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 20,069 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 843 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 708 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 17,839 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 750 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 629 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 17,973 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise deriv | 2013-03-07 | 2013-03-11 | 20,220 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 843 | $13.44 | $11.3K | 58,411 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 1,852 | $25.92 | $48.0K | 1,352,100 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 78 | $25.92 | $2.0K | 57,568 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 66 | $25.92 | $1.7K | 48,317 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 1,866 | $25.92 | $48.4K | 898,669 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 17,839 | $2.69 | $48.0K | 1,353,952 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 750 | $2.69 | $2.0K | 57,646 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 629 | $2.69 | $1.7K | 48,383 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 17,973 | $2.69 | $48.3K | 900,535 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 10,407 | $25.92 | $269.7K | 1,361,762 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 438 | $25.92 | $11.4K | 57,973 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 368 | $25.92 | $9.5K | 48,657 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-07 | 2013-03-11 | 10,485 | $25.92 | $271.8K | 908,404 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 20,069 | $13.44 | $269.7K | 1,372,169 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 20,220 | $13.44 | $271.8K | 918,889 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | X Exercise | 2013-03-07 | 2013-03-11 | 708 | $13.44 | $9.5K | 49,025 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-01-24 | 2013-04-15 | 500,000 | $18.93 | $9.46M | 882,562 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-01-24 | 2013-01-25 | 500,000 | $18.93 | $9.46M | 882,562 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2012-12-06 | 2013-04-15 | 98,596 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2012-12-06 | 2013-01-25 | 98,596 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 650,000 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,811,735 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 1,683,879 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 1,666,667 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,469,034 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,738,386 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | C Conversion deriv | 2012-04-16 | 2013-04-16 | 2,200,490 | — | $0 | 0 | SEC↗ |
| ECYT ENDOCYTE INC | P Buy | 2011-12-21 | 2012-01-11 | 197,800 | $3.16 | $625.0K | 831,461 | SEC↗ |
| ECYT ENDOCYTE INC | P Buy | 2011-12-20 | 2012-01-11 | 197,800 | $3.20 | $633.0K | 633,661 | SEC↗ |